Video | A New Possible Treatment for PV with Silence Therapeutics
On May 20th, 2025, the Global MPN Scientific Foundation hosted a webinar featuring Silence Therapeutics, a UK-based biotech company exploring RNA-based therapies for Polycythemia Vera (PV).The first part of the session featured Alberto Martinez, Senior Director of Clinical Science, who presented divesiran, an investigational RNA interference therapy currently in development for PV. He explained th
June 30, 2025